Company: NUTR
Filing Date: 2025-03-21
Form Type: S-1
Source: 0001641172-25-000122
Chunk: 5

Company: NUSATRIP Inc
Filing Date: 2025-03-21
Form: S-1
Chunk 5
---
 of the Company’s Common Stock. Under these rules, a company of which more than 50% of the voting power is held by an individual, group or another company is a controlled company and may elect not to comply with certain corporate governance requirements, including the requirement that a majority of its directors be independent, as defined in the Corporate Governance Rules of Nasdaq and the requirement that the compensation committee and nominating and corporate governance committee of the Company consist entirely of independent directors. The Company currently does not intend to rely on these exemptions. However, if the Company decides to rely on exemptions applicable to controlled company under the Corporate Governance Rules of Nasdaq in the future, you will not have the same protections afforded to stockholders of companies that are subject to all of Nasdaq corporate governance requirements. See “Risk Factors — the Company will be a “controlled company” within the meaning of the NASDAQ corporate governance standards and, as a result, will be entitled to rely on exemptions from certain corporate governance requirements that provide protections to stockholders”and “Controlled Company Exemption.”In addition, upon the consummation of this offering, Society Pass Incorporated will control 77.5% of the voting power of the Company’s outstanding voting securities.

|                              |     | Per   
 Share |     | Total |
|:-----------------------------|:----|:------|:----|:------|
| Public offering              
 price                        |     | $     |     | $     |
| Underwriting                 
 discounts and commissions(1) |     | $     |     | $     |
| Proceeds                     
 to us, before expenses(2)    |     | $     |     | $     |

(1) We have agreed to pay Cathay Securities, Inc., as the representative (the “Representative”) of the underwriters named in this prospectus, an underwriting discount equal to seven percent (7.0%) of the gross proceeds of the offering.

(2) The amount of offering proceeds to us presented in this table does not give effect to the exercise of the over-allotment option issued to the Underwriter.

We have agreed to issue to the Representative, on the closing date of this offering, warrants in an amount equal to seven percent (7.0%) of the aggregate number of shares of Common Stock sold by us in this offering and exercisable at a price per share equal to one hundred and twenty-five percent (125%) of the public offering price (the “Underwriter’s Warrants”). In addition, we have